Cost-Effectiveness of Zanubrutinib Versus Bendamustine and Rituximab in Patients With Untreated Chronic Lymphocytic Leukemia
| Autor: | Nie, Jing, Liu, Lihui, Wu, Huina, Yuan, Shan, Tang, Ke, Wu, Jiyong |
|---|---|
| Zdroj: | In Clinical Therapeutics November 2024 46(11):877-882 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect